1. Home
  2. ETY vs NVAX Comparison

ETY vs NVAX Comparison

Compare ETY & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

ETY

Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

N/A

Current Price

$13.58

Market Cap

2.2B

Sector

Finance

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETY
NVAX
Founded
N/A
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
ETY
NVAX
Price
$13.58
$8.52
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $14.11
AVG Volume (30 Days)
307.3K
★ 6.1M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 309.76
EPS
★ N/A
N/A
Revenue
N/A
★ $1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$13.12
$6.20
52 Week High
$15.77
$13.39

Technical Indicators

Market Signals
Indicator
ETY
NVAX
Relative Strength Index (RSI) 43.45 37.52
Support Level $13.19 $7.81
Resistance Level $14.79 $10.53
Average True Range (ATR) 0.21 0.76
MACD 0.01 -0.16
Stochastic Oscillator 44.60 5.98

Price Performance

Historical Comparison
ETY
NVAX

About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: